Symbols

ICUI

ICU Medical·NASDAQ

--(--)

ICUI fundamentals

ICUI Q4 2025 Earnings

ICU Medical (ICUI) released its earnings on Feb 19, 2026: revenue was 535.94M (YoY -13.78%), beat estimates; EPS was 1.91 (YoY -9.48%), beat estimates.

Revenue / YoY

535.94M

-13.78%

EPS / YoY

1.91

-9.48%

Report date

Feb 19, 2026

ICUI Earnings Call Summary for Q4,2025

Revenue Growth: 5% organic FY25; low to mid-single-digit 2026 guidance.
Margin Expansion: 2026 gross margin target 41%; 2027+ benefits from completed integrations.
Free Cash Flow: Expected improvement in 2026, targeting 2x leverage by 2027.
Strategic Moves: JV with Otsuka to modernize IV Solutions; exploring Vital Care alternatives.
Tariff Impact: 2026 impact ~$25 million; pricing and operational mitigation underway.

Earnings

EPS

Revenue

Revenue & Expenses

ICUI has released its 2025 Q4 earnings report, with revenue of 540.70M, reflecting a YoY change of -14.15%, and net profit of -15.73M, showing a YoY change of 33.97%. The Sankey diagram below clearly presents ICUI's revenue sources and cost distribution.

Key Indicators

ICU Medical (ICUI) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

ICU Medical (ICUI)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.

Trend

Breakdown

Balance Sheet

ICU Medical (ICUI)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.

Trend

Breakdown

Cash Flow

ICU Medical (ICUI)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.

Trend

Breakdown